SCHEMBL830269

SCHEMBL830269

O=c1oc2ccc(Cl)cc2cc1S(=O)(=O)CS(=O)(=O)c1cc2cc(Cl)ccc2oc1=O

nearest known ligand 0.70

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CA1 P00915 7/20 0.70
CA2 P00918 7/20 0.70
CA12 O43570 6/20 0.70
CA9 Q16790 6/20 0.70
MAOB P27338 4/20 0.58
KDM4E B2RXH2 4/20 0.51
GPR35 Q9HC97 2/20 0.51
ALDH1A1 P00352 1/20 0.51
CYP1A2 P05177 1/20 0.51
CYP2C9 P11712 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
KMT2A Q03164 1/20 0.50
TSHR P16473 1/20 0.48
MMP2 P08253 1/20 0.46
MMP9 P14780 1/20 0.46
ADAM17 P78536 1/20 0.46
AKR1B1 P15121 1/20 0.45
CCR2 P41597 1/20 0.45
HSD17B10 Q99714 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL830280 0.85 CA12 (0.77) CA1CA2CA12CA9MAOB
SCHEMBL830942 0.81 CA12 (0.70) CA1CA2CA12CA9GPR35
SCHEMBL830091 0.81 CA12 (0.47) CA1CA2CA12CA9KDM4E
SCHEMBL21033100 0.80 CA12 (0.68) CA1CA2CA12CA9MAOB
SCHEMBL829617 0.78 CA12 (0.57) CA1CA2CA12CA9MAOB
SCHEMBL830002 0.78 MAOB (0.58) CA1CA2CA12CA9MAOB
SCHEMBL21033640 0.78 CA12 (0.65) CA1CA2CA12CA9MAOB
SCHEMBL830675 0.78 MAOB (0.51) CA1CA2CA12CA9MAOB
SCHEMBL829995 0.78 MAOB (0.51) CA1CA2CA12CA9MAOB
SCHEMBL829994 0.78 MAOB (0.51) CA1CA2CA12CA9MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070232649-A1 Heteroaryl Sulfones and Sulfonamides and Therapeutic Uses Thereof TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2007-10-04 US claimed
EP-1765804-A2 HETEROARYL SULFONES AND SULFONAMIDES AND THERAPEUTIC USES THEREOF Temple University of the Commonwealth System of Higher Education (US) 2007-03-28 EP claimed
WO-2005123077-A2 HETEROARYL SULFONES AND SULFONAMIDES AND THERAPEUTIC USES THEREOF TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2005-12-29 WO claimed
US-8143428-B2 Heteroaryl sulfones and sulfonamides and therapeutic uses thereof TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2012-03-27 US disclosed
US-20070232649-A1 Heteroaryl Sulfones and Sulfonamides and Therapeutic Uses Thereof TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2007-10-04 US disclosed
EP-1765804-A2 HETEROARYL SULFONES AND SULFONAMIDES AND THERAPEUTIC USES THEREOF Temple University of the Commonwealth System of Higher Education (US) 2007-03-28 EP disclosed
WO-2005123077-A2 HETEROARYL SULFONES AND SULFONAMIDES AND THERAPEUTIC USES THEREOF TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2005-12-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070232649-A1 Heteroaryl Sulfones and Sulfonamides and Therapeutic Uses Thereof SULT1E1, STS, CCNE1 CA1 3859/4885CA2 2552/4885CA12 2448/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.